Document Detail


Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart.
MedLine Citation:
PMID:  7858738     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Disorders of the cardiovascular system often are associated with alterations in the metabolism of the collagens of these tissues. A method for in vivo determination of collagen deposition rate in small tissue samples is delineated and used for assessment of the effect of biosynthetic growth hormone (GH) injections on the collagen deposition rate in rat aorta and cardiac musculature. Rats were injected with GH, and the controls with saline, twice daily for 7 days. The in vivo collagen deposition rate was measured by injecting iv a large dose of [3H]-proline with a flooding dose of "cold" proline, followed by determination of the production of [3H]-hydroxyproline during a 4-h labelling period. Extractable collagens that were not bound in the tissue and therefore do not contribute mechanical strength to it were removed from the samples. 3H-Labelled- and "cold" amino acids were assessed by reversed-phase HPLC combined with simultaneous flow scintillation detection on the same sample. In the control group the deposition per hour was 0.13 +/- 0.02% (mean +/- SEM) in aortic intima media and 0.72 +/- 0.09% in cardiac left ventricular musculature. Growth hormone induced a threefold increase (p < 0.001 and p < 0.01, respectively) in the collagen deposition rate: 0.45 +/- 0.06% in aortic intima media and 2.43 +/- 0.45% in cardiac left ventricular musculature. The method described enables a rapid and sensitive determination of collagen deposition per hour in small tissue samples from experimental animals. The collagen deposition rate of cardiac musculature is fivefold higher compared with that of aortic intima media.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
A Brüel; H Oxlund
Related Documents :
20307688 - Cardiac mast cell proteases do not contribute to the regulation of the rat coronary vas...
20930148 - Angiotensin-converting enzyme inhibition prevents the release of monocytes from their s...
15010278 - Connective tissue growth factor--a novel mediator of angiotensin ii-stimulated cardiac ...
3435518 - Dna synthesis in myocytes from different myocardial compartments of young rats in norm,...
2432518 - What is the most appropriate stimulation mode in patients with sinus node dysfunction?
7412338 - Clinical comparison between patients with saphenous vein and internal mammary artery as...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European journal of endocrinology / European Federation of Endocrine Societies     Volume:  132     ISSN:  0804-4643     ISO Abbreviation:  Eur. J. Endocrinol.     Publication Date:  1995 Feb 
Date Detail:
Created Date:  1995-03-21     Completed Date:  1995-03-21     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  9423848     Medline TA:  Eur J Endocrinol     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  195-9     Citation Subset:  IM    
Affiliation:
Department of Connective Tissue Biology, University of Aarhus, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aorta / metabolism*
Chromatography, High Pressure Liquid
Collagen / biosynthesis*
Female
Growth Hormone / pharmacology*
Myocardium / metabolism*
Proline / metabolism
Rats
Rats, Wistar
Tritium
Chemical
Reg. No./Substance:
10028-17-8/Tritium; 147-85-3/Proline; 9002-72-6/Growth Hormone; 9007-34-5/Collagen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sulfoconjugated and free plasma catecholamine levels at rest and during exercise in patients with id...
Next Document:  Epidermal growth factor stimulates the cell growth of the PA-1 teratocarcinoma cell line in an autoc...